Overview Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin Status: Completed Trial end date: 2015-10-01 Target enrollment: Participant gender: Summary Effect of Dapagliflozin on 24-hour Blood Glucose in Type 2 Diabetes Patients Inadequately Controlled With Either Metformin Or Insulin Phase: Phase 4 Details Lead Sponsor: AstraZenecaTreatments: DapagliflozinInsulinInsulin, Globin ZincMetformin